Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.

Cong LiFangxiao LuTao LeiHaifeng YuXi ChenShuailing PengShuiyun HanHaiyan Yang

Published in: BMC cancer (2020)

This study revealed that the occurrence of IP was common in B-cell NHL patients undergoing combined chemotherapy plus rituximab treatment. IP could be reduced with prophylactic treatment of once-daily oral TMP-SMX.

Keyphrases

patients undergoing
physical activity
risk factors
single cell
replacement therapy
mechanical ventilation
acute respiratory distress syndrome